| The 2007 WHO classification of tumours of the central nervous system DN Louis, H Ohgaki, OD Wiestler, WK Cavenee, PC Burger, A Jouvet, ... Acta neuropathologica 114, 97-109, 2007 | 19587 | 2007 |
| The 2016 World Health Organization classification of tumors of the central nervous system: a summary DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ... Acta neuropathologica 131, 803-820, 2016 | 17218 | 2016 |
| WHO classification of tumours of endocrine organs 김나래 IARC, 2017 | 2385 | 2017 |
| Genetic pathways to primary and secondary glioblastoma H Ohgaki, P Kleihues The American journal of pathology 170 (5), 1445-1453, 2007 | 2064 | 2007 |
| Genetic pathways to glioblastoma: a population-based study H Ohgaki, P Dessen, B Jourde, S Horstmann, T Nishikawa, PL Di Patre, ... Cancer research 64 (19), 6892-6899, 2004 | 1883 | 2004 |
| Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas H Ohgaki, P Kleihues Journal of Neuropathology & Experimental Neurology 64 (6), 479-489, 2005 | 1857 | 2005 |
| Epidemiology and etiology of gliomas H Ohgaki, P Kleihues Acta neuropathologica 109, 93-108, 2005 | 1771 | 2005 |
| The definition of primary and secondary glioblastoma H Ohgaki, P Kleihues Clinical cancer research 19 (4), 764-772, 2013 | 1588 | 2013 |
| IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas T Watanabe, S Nobusawa, P Kleihues, H Ohgaki The American journal of pathology 174 (4), 1149-1153, 2009 | 1284 | 2009 |
| A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal G Rindi, DS Klimstra, B Abedi-Ardekani, SL Asa, FT Bosman, E Brambilla, ... Modern Pathology 31 (12), 1770-1786, 2018 | 1075 | 2018 |
| Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas K Watanabe, O Tachibana, K Sato, Y Yonekawa, P Kleihues, H Ohgaki Brain pathology 6 (3), 217-223, 1996 | 1015 | 1996 |
| Primary and secondary glioblastomas: from concept to clinical diagnosis P Kleihues, H Ohgaki Neuro-oncology 1 (1), 44-51, 1999 | 949 | 1999 |
| IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas S Nobusawa, T Watanabe, P Kleihues, H Ohgaki Clinical Cancer Research 15 (19), 6002-6007, 2009 | 902 | 2009 |
| I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ... Brain pathology 24 (5), 429-435, 2014 | 694 | 2014 |
| Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype M Olivier, DE Goldgar, N Sodha, H Ohgaki, P Kleihues, P Hainaut, ... Cancer research 63 (20), 6643-6650, 2003 | 682 | 2003 |
| Genetic alterations and signaling pathways in the evolution of gliomas H Ohgaki, P Kleihues Cancer science 100 (12), 2235-2241, 2009 | 622 | 2009 |
| Epidemiology of brain tumors H Ohgaki Cancer Epidemiology: Modifiable Factors, 323-342, 2009 | 600 | 2009 |
| Tumors associated with p53 germline mutations: a synopsis of 91 families. P Kleihues, B Schäuble, A zur Hausen, J Estève, H Ohgaki The American journal of pathology 150 (1), 1, 1997 | 590 | 1997 |
| Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas Y Okamoto, PL Di Patre, C Burkhard, S Horstmann, B Jourde, M Fahey, ... Acta neuropathologica 108, 49-56, 2004 | 450 | 2004 |
| Carcinogenicities of heterocyclic amines in cooked food H Ohgaki, S Takayama, T Sugimura Mutation Research/Genetic Toxicology 259 (3-4), 399-410, 1991 | 440 | 1991 |
Paul KleihuesMedical Faculty, University of ZurichVerified email at pathol.uzh.ch
